IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FRANCESCHINI, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.705
EU - Europa 11.572
AS - Asia 10.937
SA - Sud America 2.102
Continente sconosciuto - Info sul continente non disponibili 562
AF - Africa 277
OC - Oceania 26
AN - Antartide 1
Totale 45.182
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.187
IT - Italia 5.245
SG - Singapore 3.854
CN - Cina 3.287
BR - Brasile 1.719
UA - Ucraina 1.486
HK - Hong Kong 1.260
DE - Germania 1.208
VN - Vietnam 735
FR - Francia 669
FI - Finlandia 609
GB - Regno Unito 553
BD - Bangladesh 540
RU - Federazione Russa 422
TR - Turchia 387
IE - Irlanda 375
IN - India 260
CA - Canada 240
PL - Polonia 211
NL - Olanda 160
SE - Svezia 136
AR - Argentina 130
MX - Messico 124
ES - Italia 92
ZA - Sudafrica 92
IQ - Iraq 89
JP - Giappone 83
AT - Austria 66
PK - Pakistan 62
EC - Ecuador 55
ID - Indonesia 54
VE - Venezuela 52
CO - Colombia 51
BE - Belgio 49
SA - Arabia Saudita 43
JM - Giamaica 34
MA - Marocco 34
CZ - Repubblica Ceca 31
EG - Egitto 29
EE - Estonia 28
LT - Lituania 28
NG - Nigeria 28
UZ - Uzbekistan 28
CR - Costa Rica 27
JO - Giordania 27
AE - Emirati Arabi Uniti 25
PY - Paraguay 25
CL - Cile 23
RO - Romania 22
AU - Australia 21
KE - Kenya 21
AZ - Azerbaigian 20
HN - Honduras 20
HR - Croazia 20
PH - Filippine 20
CH - Svizzera 19
IL - Israele 19
PE - Perù 19
TT - Trinidad e Tobago 19
PT - Portogallo 18
TN - Tunisia 18
NP - Nepal 17
UY - Uruguay 17
DZ - Algeria 16
KZ - Kazakistan 16
EU - Europa 14
GR - Grecia 13
SK - Slovacchia (Repubblica Slovacca) 13
AL - Albania 12
IR - Iran 12
MY - Malesia 12
KG - Kirghizistan 11
MK - Macedonia 11
TH - Thailandia 11
LB - Libano 10
LU - Lussemburgo 10
BG - Bulgaria 9
NI - Nicaragua 9
PA - Panama 8
BO - Bolivia 7
CI - Costa d'Avorio 7
GT - Guatemala 7
HU - Ungheria 7
NO - Norvegia 7
PS - Palestinian Territory 7
RS - Serbia 7
SV - El Salvador 7
BA - Bosnia-Erzegovina 6
BH - Bahrain 6
ET - Etiopia 6
GE - Georgia 6
LV - Lettonia 6
UG - Uganda 6
AM - Armenia 5
BY - Bielorussia 5
CY - Cipro 5
DK - Danimarca 5
KR - Corea 5
PR - Porto Rico 5
AO - Angola 4
Totale 44.555
Salva come PNG Salva come JPEG
Città #
Singapore 2.020
Ashburn 1.678
Fairfield 1.572
Hong Kong 1.256
Woodbridge 1.144
San Jose 1.143
Jacksonville 1.097
Houston 846
Beijing 783
The Dalles 764
Cambridge 625
Seattle 608
Ann Arbor 587
Wilmington 578
Princeton 552
New York 538
Chandler 477
Los Angeles 474
Council Bluffs 471
Milan 463
Helsinki 371
Nanjing 352
Lauterbourg 311
Dallas 306
Dublin 305
Istanbul 304
Chicago 290
Columbus 283
Rome 272
Ho Chi Minh City 250
Brescia 240
Munich 226
Warsaw 187
Buffalo 181
Hanoi 155
Moscow 152
Santa Clara 149
São Paulo 148
Des Moines 130
San Francisco 128
Redondo Beach 127
Florence 125
Nanchang 122
San Diego 117
Shanghai 110
Hebei 105
Shenyang 105
London 98
Changsha 97
Tianjin 88
Salt Lake City 87
Turin 80
Phoenix 78
Tokyo 74
Turku 74
Jinan 73
Bologna 69
Nuremberg 67
Verona 67
Orem 65
Atlanta 64
Trieste 64
Brooklyn 63
Jiaxing 63
Lancaster 61
Rio de Janeiro 59
Toronto 58
Hangzhou 56
Chennai 55
Bergamo 54
Frankfurt am Main 53
Montreal 53
Johannesburg 52
Mexico City 49
Genoa 47
Brussels 45
Denver 45
Dearborn 43
Naples 42
Belo Horizonte 41
Guangzhou 41
Amsterdam 40
Tampa 39
Elk Grove Village 38
Kunming 35
Stockholm 34
Udine 34
Dhaka 33
Manchester 33
Mumbai 33
Ningbo 33
Romola 33
Vienna 33
Brasília 32
Charlotte 32
Padova 32
Miami 31
Lappeenranta 30
Poplar 30
Zhengzhou 30
Totale 25.987
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.404
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.863
Frequency Evaluation of the Interleukin-6 −174G>C Polymorphism and Homeostatic Iron Regulator (HFE) Mutations as Disease Modifiers in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis 711
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 504
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 258
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 225
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 225
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 222
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 220
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study 208
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 208
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 199
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 198
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 197
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 196
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 195
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 191
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 189
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 187
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 187
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 186
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 183
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 183
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 182
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 180
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 180
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 179
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 178
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 177
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 175
Antiphospholipid antibodies mediate autoimmunity against dying cells. 174
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 174
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 174
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 172
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 172
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 172
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 166
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 166
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 165
The clinico-serological spectrum of overlap myositis 161
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 160
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 159
Autoimmune polyendocrine Syndromes 158
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 158
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 158
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 158
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 158
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 157
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 157
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 157
Clinical and morphological features of kidney involvement in primary Sjogren's syndrome. 156
Relationship between endothelial dysfunction, videocapillaroscopy and circulating CD3+CD31+CXCR4+ lymphocytes in systemic lupus erythematosus without cardiovascular risk factors 155
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 151
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 150
Severe skin involvement in type II cryoglobulinemia successfully treated with thalidomide 149
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 149
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 148
Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus 147
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 147
Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis 146
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 145
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 145
Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker 144
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 144
A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. 144
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 142
Anti-Ro/SSA and La/SSB antibodies 142
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 142
The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies. 141
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients 141
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 139
Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: The positive experience of a national multicentre study 139
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 137
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 137
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 136
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 134
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 134
Systematic Review and Meta-analysis on the Association of Occupational Exposure to Free Crystalline Silica and Rheumatoid Arthritis 134
Anti-topoisomerase-I antibodies in systemic lupus erythematosus and potential association with the presence of anti-dsDNA antibodies 133
Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. 132
Deforming arthropathy of the hands in Systemic Lupus Erythematosus is associated with antibodies to SS-A/Ro and to SS-B/La. 132
Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference 132
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 132
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus 132
In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings. 132
Incidence of antiperinuclear factor in patients with psoriatic arthritis. 131
Belimumab decreases flare rate and hinders the expected damage progression in patients with active systemic lupus erythematosus 131
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 130
75-SeHCAT retention test in chronic cholestatic disease: comparison with health and effect of bile acid therapy. 130
Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors 130
Myositis autoantibodies and clinical phenotypes 130
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group 130
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 129
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 129
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 129
Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience. 129
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 128
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 128
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 128
Antinuclear antibodies in psoriatic arthritis and its subgroups 127
Totale 20.748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 219.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.419
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.424 0 0 140 176 164 200 201 234 193 296 272 548
2022/20232.266 341 38 51 99 194 564 47 229 384 56 139 124
2023/20242.853 150 84 228 246 134 458 134 138 667 94 107 413
2024/20257.324 117 156 125 734 678 592 568 343 675 585 1.492 1.259
2025/202613.956 1.224 1.862 1.068 1.878 1.336 929 2.057 583 767 1.147 688 417
2026/20272.242 783 770 689 0 0 0 0 0 0 0 0 0
Totale 45.182